Background illustration for clinical trials search

Paid Clinical Trials Quebec

Discover 1,431 paid clinical trials in Quebec. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,431

Study of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's Disease

for

Alzheimer Disease, Alzheimer Disease, Early Onset

Location: Montreal, East York, Toronto

Sponsor: Arrowhead Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07221344

Phase 1, Phase 2, Recruiting

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

for

Chronic Myelogenous Leukemia,

Location: New York NY, New Brunswick NJ, Montreal, Cincinnati OH,

Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 1 - 18

Code: NCT07354074

Phase 2, Recruiting

Female Reproductive Health in Canadian Armed Forces

for

Pregnancy, Pelvic Floor Dysfunction, Military Personnel,

Location: Sherbrooke

Sponsor: Université de Sherbrooke

Sex: Female

Age: 18+

Code: NCT07524764

Recruiting

Recovery With Exogenous Ketones and Antipsychotics

for

First Episode Psychosis

Location: Sherbrooke

Sponsor: Université de Sherbrooke

Sex: All

Age: 18 - 35

Code: NCT07122531

Recruiting

Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder

for

Methamphetamine Abuse, Methamphetamine-dependence, Addiction,

Location: Montreal

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18 - 55

Code: NCT06788587

Phase 2, Recruiting

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

for

Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer

Location: Rimouski, Boston MA, Worcester MA, Hartford CT, Quebec,

Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06793215

Phase 3, Recruiting

This Study Investigates β-hydroxy-β-methylbutyrate (HMB) and 2-hydroxybenzylamine (2-HOBA), When Administered Either Individually or in Combination Contributes to an Increased Quality of Health, Specifically Improving Muscular Strength and Cognitive Functioning in Adults Over the Age of 65.

for

Muscle, Cognitive Functioning, Geriatric,

Location: Montreal

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 65+

Code: NCT07419633

Recruiting

Tradeoffs in Patient Decision Making About Rectal Cancer Treatment: Benefits Compared to Quality Of Life.

for

Patient Preference

Location: Montreal

Sponsor: Sir Mortimer B. Davis - Jewish General Hospital

Sex: All

Age: 18+

Code: NCT04925154

Recruiting

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

for

Familial Pulmonary Fibrosis, Interstitial Lung Abnormalities,

Location: Boston MA, New York NY, Montreal, Philadelphia PA,

Sponsor: Boehringer Ingelheim

Sex: All

Age: 40+

Code: NCT07201922

Phase 3, Recruiting

A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

for

CLL, Chronic Lymphocytic Leukemia

Location: Shirley NY, Westbury NY, New York NY, Greenfield Park,

Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06846671

Phase 3, Recruiting

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

for

Urothelial Cancer, Urinary Bladder Neoplasms

Location: Chicoutimi, New York NY, Montreal, Norfolk VA,

Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07566156

Phase 3, Recruiting

Effect of Dairy Protein Yogourt vs Plant-based Yogourt on Body Weight, Body Composition, Bone Health and Gut Microbiota

for

Body Composition Changes, Body Weight Change, Metabolic Health,

Location: Quebec

Sponsor: Laval University

Sex: Female

Age: 40+

Code: NCT07578103

Recruiting

RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

for

HER2-positive Breast Cancer

Location: Norwich CT, Shirley NY, Quebec, Stony Brook NY,

Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07413939

Phase 2, Phase 3, Recruiting

A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine

for

Lyme Disease

Location: Worcester MA, Sherbrooke, Scranton PA, Cortland NY,

Sponsor: Pfizer

Sex: All

Age: 7+

Code: NCT07500506

Phase 3, Recruiting

Feasibility and Acceptability of Collecting Sociodemographic Data in CCTG Trials

for

Cancer

Location: Saint John, Quebec, Ottawa, Kingston, Toronto, Hamilton,

Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT07390435

Recruiting

A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

for

Colitis, Ulcerative

Location: Quebec, New York NY, Indianapolis IN, Winnipeg

Sponsor: Pfizer

Sex: All

Age: 2 - 11

Code: NCT07470879

Phase 2, Recruiting

A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer

for

Metastatic Castration-resistant Prostate Cancer (mCRPC)

Location: Boston MA, Montreal, Toronto, Dallas TX

Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07570979

Phase 1, Recruiting

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

for

KRAS Altered Advanced or Metastatic Solid Tumors

Location: Boston MA, Montreal, Philadelphia PA, Fairfax VA,

Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT07094113

Phase 1, Recruiting

Perioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)

for

Urinary Bladder Neoplasms, Immune Checkpoint Inhibitors,

Location: Quebec, Sherbrooke, Montreal, Hamilton, London

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06960577

Phase 2, Recruiting

Personalized vs. Fixed-Activity 177Lu-PSMA-617 Radiopharmaceutical Therapy (PRODIGY-2)

for

Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Location: Quebec

Sponsor: Jean-Mathieu Beauregard

Sex: Male

Age: 18+

Code: NCT06943495

Phase 1, Recruiting

Popular cities in Quebec

Quebec City Montreal

Paid Clinical Trials Quebec

Filter results

Study of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's Disease

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

Female Reproductive Health in Canadian Armed Forces

Recovery With Exogenous Ketones and Antipsychotics

Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder

Interested in new trials?

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

This Study Investigates β-hydroxy-β-methylbutyrate (HMB) and 2-hydroxybenzylamine (2-HOBA), When Administered Either Individually or in Combination Contributes to an Increased Quality of Health, Specifically Improving Muscular Strength and Cognitive Functioning in Adults Over the Age of 65.

Tradeoffs in Patient Decision Making About Rectal Cancer Treatment: Benefits Compared to Quality Of Life.

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

Effect of Dairy Protein Yogourt vs Plant-based Yogourt on Body Weight, Body Composition, Bone Health and Gut Microbiota

RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine

Feasibility and Acceptability of Collecting Sociodemographic Data in CCTG Trials

A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

Perioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)

Personalized vs. Fixed-Activity 177Lu-PSMA-617 Radiopharmaceutical Therapy (PRODIGY-2)

Popular cities in Quebec